Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. (EMCURE.NS) Stock Overview
Explore Emcure Pharmaceuticals Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
271.2B
P/E Ratio
31.18
EPS (TTM)
$45.87
ROE
0.20%
EMCURE.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Emcure Pharmaceuticals Ltd. (EMCURE.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 41.51, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1506.42.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 31.18 and a market capitalization of 271.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.